Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Products>This Product
  Products


Covance, Inc.

Product Description

Covance, with headquarters in Princeton, New Jersey, is one of the world’s largest and most comprehensive drug development services companies, with annual revenues greater than $2 billion, employees in more than 60 countries, and more than 11,000 employees worldwide.

Nonclinical Development: Toxicology, Research Products, Analytical Services

• Managed 443 compound development programs (>250 IND/CTA enabling), with  over 100 different sponsors, which led to 41 IND/CTA applications in 2009
• Performed best-in-class productivity cycle times: FIA to FIH in 22 weeks
• Dedicated Capacity Agreements with several major pharma customers
• Greater than 2.5M sq ft of research space

Clinical Development: Clinical Pharmacology, Clinical, Central Labs

• Supported 50% of latest breakthrough cancer treatments
• Supported development of the top 25 currently marketed medicines
• 70% of clinical programs on or ahead of enrollment timelines
• Broad-based, scalable and market-leading, Biomarker capability
• 99% of samples received within stability
• 145 million laboratory tests; 83,000 investigator sites; 100 countries
• Seven Clinical Pharmacology units with ~500 beds

Periapproval & Market Access

• Results-driven reimbursement support for >60% of the biologics market
• Designed and managed world’s largest safety registry ever – iPledge
• Team of experts dedicated to risk management and Pharmacovigilance
• Bi-coastal call center capabilities to deliver patient and physician support
Product Covance, Inc.
Company Covance - Service Directory
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Covance - Service Directory
210 Carnegie Center Princeton, New Jersey 08540 United States

Tel: +1.888.268.2623



Scientific News
Breakthrough Flu Vaccine Inhibited by Pre-existing Antibodies
Universal truths – how existing antibodies are sabotaging the most promising new human flu vaccines.
Researchers Develop Software That Could Facilitate Drug Development
AptaTRACE can identify aptamers, potentially speed drug advancement.
Gene Therapy for Metabolic Liver Diseases
Researchers have tested gene therapy in pigs from hereditary tyrosinemia type 1, with corrected liver cells being transplanted into the diseased liver.
Zika Vaccine Candidates Show Promise
Two experimental vaccines have shown promise against a major viral strain responsible for the Brazilian Zika outbreak.
New Medication Shows Promise Against Liver Fibrosis in Animal Studies
Liver fibrosis is a gradual scarring of the liver that puts people at risk for progressive liver disease and liver failure.
Raw Eggs Deemed Safe to Eat
A report published today by the Advisory Committee on the Microbiological Safety of Food (ACMSF) into egg safety has shown a major reduction in the risk from salmonella in UK eggs.
Monitoring TTX Toxin in Shellfish
In a number of small studies, mussels and oysters from the eastern and northern part of the Oosterschelde in Holland were found to contain tetrodotoxin (TTX).
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
NIH Begins Yellow Fever Vaccine Trial
NIH has initiated an early-stage clinical trial of a vaccine to protect against yellow fever.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Scroll Up
Scroll Down

Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!